Skip Navigation


NDT Advance Access originally published online on January 8, 2007
Nephrology Dialysis Transplantation 2007 22(4):999-1001; doi:10.1093/ndt/gfl797
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
22/4/999    most recent
gfl797v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Michielsen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Michielsen, P.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2007]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

In memoriam ‘analgesic nephropathy’ (circa 1972–2006)

Paul Michielsen

Acacialaan 54; Herent, B3020, Belgium

Correspondence and offprint requests to: Email: paul.michielsen@med.kuleuven.be

Keywords: analgesic nephropathy; mixed analgesics; phenacetin

The first 150 words of the full text of this article appear below.

Throughout the last decades, analgesic nephropathy (AN) has remained a subject for controversy, leading to a series of epidemiological studies, reviews, statements by more or less officially appointed committees and appeals to public health authorities. In contrast, the ‘Obituary to Analgesic Nephropathy’ which appeared in the November issue of NDT [1] reports only a decisive new fact: 20 years after the removal of phenacetin from the freely available analgesics, the typical lesions of AN are no longer found at autopsy in Basel. How does this new evidence fit into the other available pieces of the puzzle?

It all started in the 50s, with localized epidemics of chronic renal failure in Sweden, in Swiss watch factories, in the Flanders region of Belgium and in Australia. All had in common a compulsive craving for analgesic mixtures, usually powders containing phenacetin combined with other antipyretic analgesics, caffeine and sometimes codeine. The . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?